Oncothyreon Announces First Quarter 2013 Financial Results Conference Call
SEATTLE, WA, May 2, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, May 9, 2013 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its first quarter 2013 financial results and provide a review of its pipeline of products in development.
To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International). In addition, the call will be webcast live and can be accessed on the "Events" page of the "News & Events" section of Oncothyreon's website at www.oncothyreon.com. An archive of the webcast will be available after completion of the discussion and will be posted on the Oncothyreon website.
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
More by this Source
Oncothyreon Reports Full Year and Fourth Quarter 2013 Financial Results
Mar 13, 2014, 16:01 ET
Oncothyreon Announces Full Year and Fourth Quarter 2013 Financial Results Conference Call
Mar 06, 2014, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.